Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

GSK Makes Pact With India's Dr. Reddy's

by Michael McCoy
June 22, 2009 | A version of this story appeared in Volume 87, Issue 25

GlaxoSmithKline has formed an alliance with Dr. Reddy's Laboratories under which it will market some of the Indian company's products in emerging markets, except India. "This is another significant step forward in our strategy to grow and diversify GSK's business in emerging markets," says Abbas Hussain, GSK's president for emerging markets. GSK recently acquired a 16% stake in South Africa's Aspen Pharmacare. The deal with Dr. Reddy's provides more than 100 branded drugs to market in Africa, the Middle East, Asia-Pacific, and Latin America.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.